Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory Science
DiMe experts co-authored this publication on how the advancement of DHT can be most effectively be achieved by aligning knowledge, expertise, and data sharing in ways that maximize efficiencies; and additionally, can specifically support the advancement of Parkinson Disease treatments.